insights_auto
Why is CATX down 8.17%?
Dive Deeperchevron_right
CATX:NYSEAMERICAN
Perspective Therapeutics Inc
$2.36
arrow_downward
-8.17%(-0.21) 1D
$2.37
arrow_upward
+0.42% (+0.0100)bedtimeAfter hours
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CATX...
Open
$2.59
High
$2.60
Low
$2.30
Mkt. cap
289.31M
Avg. vol.
1.97M
Volume
2.67M
52-wk high
$6.16
52-wk low
$1.96
EPS
-$1.33
Beta
1.84
Shares outstanding
114.15M
No. of employees
163
Open
$2.59
High
$2.60
Low
$2.30
Mkt. cap
289.31M
Avg. vol.
1.97M
Volume
2.67M
52-wk high
$6.16
52-wk low
$1.96
EPS
-$1.33
Beta
1.84
Shares outstanding
114.15M
No. of employees
163
News stories
From web sources and news partners
Fox News
·
25 minutes ago
Fox News Media CEO Suzanne Scott rings Nasdaq closing bell in honor of network's 30th anniversary
GlobeNewswire
·
43 minutes ago
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Simply Wall Street
·
7 minutes ago
3 Software Stocks in the AI Security Spend Shift After the OpenAI Breach
WSJ
·
21 minutes ago
U.S. Stocks Rise as AI Momentum Builds
Profile
Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu.
The company went public in 2005. Isoray’s corporate headquarters is located at 350 Hills Street, Suite 106, Richland WA 99354. Wikipedia
About Perspective Therapeutics Inc
CEO-
Employees163
Founded2004
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Websiteperspectivetherapeutics.com